Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic

Simple item page
dc.contributor.authorPriya, Gaganen_ZA
dc.contributor.authorBajaj, Saritaen_Za
dc.contributor.authorKalra, Bhartien_ZA
dc.contributor.authorCoetzee, Ankiaen_ZA
dc.contributor.authorKalra, Sanjayen_ZA
dc.contributor.authorDutta, Deepen_ZA
dc.contributor.authorLim, Vivienen_ZA
dc.contributor.authorDiwakar, Hemaen_ZA
dc.contributor.authorDeshmukh, Vaishalien_ZA
dc.contributor.authorMehta, Roopaen_ZA
dc.contributor.authorSahay, Rakeshen_ZA
dc.contributor.authorGupta, Yashdeepen_ZA
dc.contributor.authorSharma, J. B.en_ZA
dc.contributor.authorDasgupta, Arundhatien_ZA
dc.contributor.authorPatnala, S.en_ZA
dc.contributor.authorAfsana, Fariaen_ZA
dc.contributor.authorGiri, Mimien_ZA
dc.contributor.authorSheikh, Aishaen_ZA
dc.contributor.authorBaruah, Manash P.en_ZA
dc.contributor.authorAsirvatham, A. R.en_ZA
dc.contributor.authorSheikh, Shehlaen_ZA
dc.contributor.authorCooray, Samanthien_ZA
dc.contributor.authorAcharya, Kirtidaen_ZA
dc.contributor.authorLangi, Y. A.en_ZA
dc.contributor.authorJacob, Jubbin J.en_ZA
dc.contributor.authorMalhotra, Jaideepen_ZA
dc.contributor.authorGeorge, Belindaen_ZA
dc.contributor.authorGrewal, Emmyen_ZA
dc.contributor.authorChandrasekharan, Srutien_ZA
dc.contributor.authorNadeem, Sarahen_ZA
dc.contributor.authorLamptey, Robertaen_ZA
dc.contributor.authorKhandelwal, Deepaken_ZA
dc.date.accessioned2023-03-22T09:49:24Zen_ZA
dc.date.available2023-03-22T09:49:24Zen_ZA
dc.date.issued2021-12en_ZA
dc.descriptionCITATION: Priya G, Bajaj S, Kalra B, Coetzee A, Kalra S, Dutta D, et al. Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic. J Family Med Prim Care 2021;10:4350-63. doi.10.4103/jfmpc.jfmpc_653_21en_ZA
dc.descriptionThe original publication is available at: lww.comen_ZA
dc.description.abstractThe human coronavirus disease 2019 (COVID‑19) pandemic has affected overall healthcare delivery, including prenatal, antenatal and postnatal care. Hyperglycemia in pregnancy (HIP) is the most common medical condition encountered during pregnancy. There is little guidance for primary care physicians for providing delivery of optimal perinatal care while minimizing the risk of COVID‑19 infection in pregnant women. This review aims to describe pragmatic modifications in the screening, detection and management of HIP during the COVID‑ 19 pandemic. In this review, articles published up to June 2021 were searched on multiple databases, including PubMed, Medline, EMBASE and ScienceDirect. Direct online searches were conducted to identify national and international guidelines. Search criteria included terms to extract articles describing HIP with and/or without COVID‑19 between 1st March 2020 and 15th June 2021. Fasting plasma glucose, glycosylated hemoglobin (HbA1c) and random plasma glucose could be alternative screening strategies for gestational diabetes mellitus screening (at 24–28 weeks of gestation), instead of the traditional 2 h oral glucose tolerance test. The use of telemedicine for the management of HIP is recommended. Hospital visits should be scheduled to coincide with obstetric and ultrasound visits. COVID‑19 infected pregnant women with HIP need enhanced maternal and fetal vigilance, optimal diabetes care and psychological support in addition to supportive measures. This article presents pragmatic options and approaches for primary care physicians, diabetes care providers and obstetricians for GDM screening, diagnosis and management during the pandemic, to be used in conjunction with routine antenatal care.en_ZA
dc.description.versionPublisher’s versionen_ZA
dc.format.extent14 pagesen_ZA
dc.identifier.citationPriya G, Bajaj S, Kalra B, Coetzee A, Kalra S, Dutta D, et al. Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic. J Family Med Prim Care 2021;10:4350-63. doi.10.4103/jfmpc.jfmpc_653_21en_ZA
dc.identifier.issn2249-4863 (print)en_ZA
dc.identifier.issn2278-7135 (online)en_ZA
dc.identifier.otherdoi.10.4103/jfmpc.jfmpc_653_21en_ZA
dc.identifier.urihttp://hdl.handle.net/10019.1/126691en_ZA
dc.language.isoen_ZAen_ZA
dc.publisherWolters Kluweren_ZA
dc.rights.holderAuthors retain copyrighten_ZA
dc.subjectCovid‑19en_ZA
dc.subjectDiabetes in pregnancyen_ZA
dc.subjectHyperglycemiaen_ZA
dc.subjectPregnancy -- Complicationsen_ZA
dc.subjectCOVID-19 (Disease)en_ZA
dc.subjectPregnancyen_ZA
dc.titleClinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemicen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
gagan_clinical_2021.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format
Description:
download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Endocrinology)